Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-055663

EVP, Chief Financial Officer bought 85,000 shares at $0.89 ($75,599)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Duarte Ira EVP, Chief Financial Officer 2023-11-16 Purchase +85,000 $0.89 $75,599 85,000 D: show line 1 in the form
Open-market purchases · 85,000 sh · avg $0.89 · $75,599
Loading xslF345X05/doc4.xml…